Last reviewed · How we verify
DNA vaccine OC-007
DNA vaccine OC-007 is a Biologic drug developed by Matti Sällberg. It is currently in Phase 1 development. Also known as: COVID-19 vaccine.
At a glance
| Generic name | DNA vaccine OC-007 |
|---|---|
| Also known as | COVID-19 vaccine |
| Sponsor | Matti Sällberg |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- DNA vaccine OC-007 CI brief — competitive landscape report
- DNA vaccine OC-007 updates RSS · CI watch RSS
- Matti Sällberg portfolio CI
Frequently asked questions about DNA vaccine OC-007
What is DNA vaccine OC-007?
DNA vaccine OC-007 is a Biologic drug developed by Matti Sällberg.
Who makes DNA vaccine OC-007?
DNA vaccine OC-007 is developed by Matti Sällberg (see full Matti Sällberg pipeline at /company/matti-s-llberg).
Is DNA vaccine OC-007 also known as anything else?
DNA vaccine OC-007 is also known as COVID-19 vaccine.
What development phase is DNA vaccine OC-007 in?
DNA vaccine OC-007 is in Phase 1.
Related
- Manufacturer: Matti Sällberg — full pipeline
- Also known as: COVID-19 vaccine
- Compare: DNA vaccine OC-007 vs similar drugs
- Pricing: DNA vaccine OC-007 cost, discount & access